SUTURA THERAPEUTICS LTD has a total of 19 patent applications. It increased the IP activity by 250.0%. Its first patent ever was published in 2015. It filed its patents most often in United Kingdom, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and biotechnology are DIATOS SA, NANJING ANJI BIOLOGICAL SCIENCE & TECH CO LTD and IDEC PHARMA CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 4 | |
#2 | Australia | 2 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Republic of Korea | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Gadd Adam James Reginald | 13 |
#2 | Foster Keith | 13 |
#3 | Eilers Wouter | 7 |
#4 | Keith Foster | 6 |
#5 | Adam James Reginald Gadd | 4 |
#6 | Wouter Eilers | 1 |
Publication | Filing date | Title |
---|---|---|
GB201710322D0 | Improvements in drug delivery | |
GB202004932D0 | Improvements in drug delivery | |
GB201912318D0 | Improved drug delivery by conjugating oligonucleotides to stitched/stapled peptides | |
GB201522548D0 | Improved drug delivery by conjugating oligonucleotides to stitched/stapled peptides |